Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Stefan Kluge0
Date of Patent
February 12, 2019
0Patent Application Number
155487370
Date Filed
February 3, 2016
0Patent Citations Received
Patent Primary Examiner
Patent abstract
Provided are crystalline forms of 2-Methyl-1-[(4-[6-(trifluoromethyl) pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol mesylate useful for treating cancer and methods of treating cancer, comprising administering to a subject in need thereof said compound.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
